DIFLUPREDNATE

Generic: DIFLUPREDNATE

Caplin Steriles LimitedManufacturer
OPHTHALMICRoute
DIFLUPREDNATEActive Substance
2024-12-13Original Approval

DIFLUPREDNATE is FDA application ANDA219441, sponsored by CAPLIN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
76 reports
2
OFF LABEL USE
59 reports
3
EYE PAIN
51 reports
4
EYE IRRITATION
36 reports
5
DIARRHOEA
32 reports
6
FATIGUE
32 reports
7
HEADACHE
32 reports
8
DECREASED APPETITE
28 reports
9
VISION BLURRED
28 reports
10
NAUSEA
26 reports